Satish Keshav
John Radcliffe Hospital · 288 works · 10,445 citations · h-index 40
Top works
- Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes
- Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation.
- Crohn’s disease and the NOD2 gene: a role for paneth cells
- Expression of NOD2 in Paneth cells: a possible link to Crohn’s ileitis
- Lysozyme is an inducible marker of macrophage activation in murine tissues as demonstrated by in situ hybridization.
- The product of the cellular crk gene consists primarily of SH2 and SH3 regions.
- Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease
- Precursor structure, expression, and tissue distribution of human guanylin.
- Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation.
- The Macrophage Scavenger Receptor Type A Is Expressed by Activated Macrophages and Protects the Host Against Lethal Endotoxic Shock
- Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up
- Cloning the human lysozyme cDNA: inverted Alu repeat in the mRNA and in situ hybridization for macrophages and Paneth cells.
- Tumor necrosis factor mRNA localized to Paneth cells of normal murine intestinal epithelium by in situ hybridization.
- Mononuclear phagocytes: tissue distribution and functional heterogeneity
- Circulating and Tissue-Resident CD4+ T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation
- The versatility of macrophages
- Correction of both prothrombin time and primary haemostasis by recombinant factor VII during therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis
- Comparing disease activity indices in ulcerative colitis
- Gastrointestinal Symptoms in 342 Patients With Fabry Disease: Prevalence and Response to Enzyme Replacement Therapy
- Does co‐treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab?